← Leaderboards
Noyan Gokce
Boston Medical Center
$15,647,950
Attributed
$19,838,041
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,838,041 · 12
By mechanism
R01$16,155,904 · 8
P01$2,588,452 · 1
K23$623,835 · 1
R21$453,750 · 1
F32$16,100 · 1
Top collaborators
- Kenneth Walsh10 shared
- Vishwajeet Puri4 shared
- Jennifer J Schlezinger1 shared
Most similar at Boston Medical Center
Same institution · by research overlap
- Lisa A. Kachnic$19,316,446
- Amresh D Hanchate$9,621,442
- Patricia L Kavanagh$2,525,680
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationObesityAdipose TissueLinkBlood VesselsCardiovascular DiseasesCardiovascular SystemResponseAreaBiopsyVascular DiseasesOverweightMetabolicPhenotypeHealthcareVisceralFunctional DisorderFatty Acid Glycerol EstersSubcutaneousAtherosclerosisMorbid ObesityCause Of DeathBiologyStroke
Grant awards (43)
Identifying environmental pollutants detrimental to the cardiovascular system$705,279
R01 · FY2025 · HL · contact PI
Wnt signaling control of vascular phenotype in obesity$596,762
R01 · FY2023 · HL · contact PI
Impact of Per/Polyfluoroalkyl pollutants on vascular disease mechanisms$453,750
R21 · FY2023 · ES · contact PI
Wnt signaling control of vascular phenotype in obesity$596,762
R01 · FY2022 · HL · contact PI
Wnt signaling control of vascular phenotype in obesity$636,513
R01 · FY2021 · HL · contact PI
Identifying a novel regulatory pathway of vascular function in obesity$547,150
R01 · FY2021 · HL · contact PI
Wnt signaling control of vascular phenotype in obesity$635,154
R01 · FY2020 · HL · contact PI
Identifying a novel regulatory pathway of vascular function in obesity$547,150
R01 · FY2020 · HL · contact PI
Wnt signaling control of vascular phenotype in obesity$612,625
R01 · FY2019 · HL · contact PI
Identifying a novel regulatory pathway of vascular function in obesity$547,150
R01 · FY2019 · HL · contact PI
Anti-Angiogenic Mechanisms in Human Obesity$478,464
R01 · FY2019 · HL · contact PI
Identifying a novel regulatory pathway of vascular function in obesity$563,317
R01 · FY2018 · HL · contact PI
Anti-Angiogenic Mechanisms in Human Obesity$478,464
R01 · FY2018 · HL · contact PI
Anti-Angiogenic Mechanisms in Human Obesity$478,464
R01 · FY2017 · HL · contact PI
Anti-Angiogenic Mechanisms in Human Obesity$478,464
R01 · FY2016 · HL · contact PI
Adipose inflammation, mitochondrial function & endothelial phenotypes in obesity$465,234
R01 · FY2016 · HL · contact PI
ADIPOSE REMODELING & VASCULAR PHENOTYPES IN OBESITY$518,965
P01 · FY2015 · HL · contact PI
Anti-Angiogenic Mechanisms in Human Obesity$478,464
R01 · FY2015 · HL · contact PI
Adipose inflammation, mitochondrial function & endothelial phenotypes in obesity$458,257
R01 · FY2015 · HL · contact PI
ADIPOSE REMODELING & VASCULAR PHENOTYPES IN OBESITY$516,331
P01 · FY2014 · HL · contact PI
Adipose inflammation, mitochondrial function & endothelial phenotypes in obesity$455,929
R01 · FY2014 · HL · contact PI
ADIPOSE REMODELING & VASCULAR PHENOTYPES IN OBESITY$501,579
P01 · FY2013 · HL · contact PI
Adipose inflammation, mitochondrial function & endothelial phenotypes in obesity$442,903
R01 · FY2013 · HL · contact PI
ADIPOSE REMODELING & VASCULAR PHENOTYPES IN OBESITY$525,622
P01 · FY2012 · HL · contact PI
Adipose inflammation, mitochondrial function & endothelial phenotypes in obesity$465,234
R01 · FY2012 · HL · contact PI
ADIPOSE REMODELING & VASCULAR PHENOTYPES IN OBESITY$525,955
P01 · FY2011 · HL · contact PI
Inflammation and Vascular Dysfunction in Obesity$477,007
R01 · FY2011 · HL · contact PI
Inflammation and Vascular Dysfunction in Obesity$467,899
R01 · FY2010 · HL · contact PI
Inflammation and Vascular Dysfunction in Obesity$467,832
R01 · FY2009 · HL · contact PI
Inflammation and Vascular Dysfunction in Obesity$458,499
R01 · FY2008 · HL · contact PI
Inflammation and Vascular Dysfunction in Obesity$457,350
R01 · FY2007 · HL · contact PI
Obesity, Adipocytokines, and Endothelial Dysfunction$450,213
R01 · FY2007 · HL · contact PI
Clinical Utility of Endothelial Function in PAD$975,965
R01 · FY2006 · HL · contact PI
Obesity, Adipocytokines, and Endothelial Dysfunction$463,660
R01 · FY2006 · HL · contact PI
Obesity, Adipocytokines, and Endothelial Dysfunction$474,818
R01 · FY2005 · HL
Obesity, Adipocytokines, and Endothelial Dysfunction$397,461
R01 · FY2004 · HL
ENDOTHELIAL DYSFUNCTION AND PERIOPERATIVE EVENTS$124,767
K23 · FY2004 · HL
Obesity, Adipocytokines, and Endothelial Dysfunction$397,461
R01 · FY2003 · HL
ENDOTHELIAL DYSFUNCTION AND PERIOPERATIVE EVENTS$124,767
K23 · FY2003 · HL
ENDOTHELIAL DYSFUNCTION AND PERIOPERATIVE EVENTS$124,767
K23 · FY2002 · HL
ENDOTHELIAL DYSFUNCTION AND PERIOPERATIVE EVENTS$124,767
K23 · FY2001 · HL
ENDOTHELIAL DYSFUNCTION AND PERIOPERATIVE EVENTS$124,767
K23 · FY2000 · HL
OXIDATIVE STRESS AND ENDOTHELIAL FUNCTION$16,100
F32 · FY2000 · HL